Testing new contraceptive methods and their effects on fertility and early embryonic development.
BIOLOGICAL TESTING FACILITY (BTF) – GOOD LABORATORY PRACTICE (GLP) TOXICOLOGY AND FERTILITY AND EARLY EMBRYONIC DEVELOPMENT (FEED) STUDIES AND PRECLINICAL STUDIES OF CONTRACEPTIVES
This study is working on creating new, safe, and affordable birth control options that can help prevent pregnancy by affecting ovulation and sperm function, so people can have more choices when it comes to contraception.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project ID | NIH-11202280 on NIH RePORTER |
What this research studies
This research focuses on developing safe and effective contraceptive agents that can disrupt normal ovulation and sperm function. The Biological Testing Facility (BTF) conducts various preclinical studies, including in vitro and in vivo assays, to evaluate new chemical entities and drug formulations. Patients may benefit from the development of new contraceptive options that are affordable and effective. The research also includes extensive testing for safety and efficacy before any clinical trials.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals seeking new contraceptive options or those interested in fertility-related studies.
Not a fit: Patients who are not interested in contraceptive methods or who have already found effective contraceptive solutions may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new contraceptive methods that are safer and more effective for patients.
How similar studies have performed: Previous research in contraceptive development has shown success in creating effective methods, indicating that this approach has potential for further advancements.
Where this research is happening
Menlo Park, United States
- Sri International — Menlo Park, United States (Active)
Researchers
- Principal investigator: Burnin, Debra — Sri International
- Study coordinator: Burnin, Debra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.